My risk perception; perspectives from youth at familial risk for bipolar disorder: a qualitative study

• by Yusef Ahmed, Freja Pind Pilegaard, Stine Pedersen, Maj Vinberg, Christina Wagner

• December 16, 2025

Sodium-Glucose Cotransporter 2 Inhibitors and Dementia Risk in Patients With Psychiatric Disorders

• by David T. Liebers, Tianshe He, Rebecca A. Betensky, Chunlei Zheng, Kaitlin N. Swinnerton, Sean Jacobson, Linden Huhmann, Mary T. Brophy, Nhan V. Do, Paola Gilsanz, Ricardo S. Osorio, Nunzio Pomara, Antonio Convit, Donald C. Goff, Dan V. Iosifescu, Nathanael R. Fillmore, Jaime Ramos-Cejudo

• June 30, 2026

Can SGLT2 Inhibitors Affect Dementia?

A target trial emulation using Veterans Affairs electronic health records examined neuropsychiatric outcomes associated with SGLT2 inhibitor use.

• by Kathryn Wighton

• July 31, 2026

• 3 min

Natural Language Processing Applied to Psychiatric Clinical Notes: Scoping Review

• by Shuying Rao, Xi'ang Chen, Guifeng Deng, Junyi Xie, Tiecheng Jiang, Tao Li, Yaoyun Zhang, Haiteng Jiang

• July 10, 2026